Year: 2006
Type: paratext
Abstract: Objective: To examine whether concomitant amlodipine use was associated with steady-state serum olanzapine concentration and clinical outcomes in patients with schizophrenia.Methods: This retrospective study included 45 inpatients with schizophrenia and hypertension who received olanzapine 10 mg/ day plus amlodipine 5 mg/day (experimental group) and 52 inpatients who received olanzapine 10 mg/day alone (control group).PANSS and SDSS scores were assessed at baseline and week 7, and recorded adverse events were evaluated at week 9. Results: Mean serum olanzapine concentration was lower in the combination group than in the olanzapine-alone group (40.56 ± 18.86 vs. 50.23 ± 23.41 ng/mL; unadjusted p = 0.027; age-adjusted p = 0.032) (Figure 1).Improvements in positive symptoms, negative symptoms, and SDSS scores were smaller in the combination group, whereas PANSS total and general psychopathology changes did not differ.Serum olanzapine concentration was not significantly correlated with any PANSS or SDSS change.Recorded adverse-event rates did not differ significantly.Conclusions: Concomitant amlodipine use was associated with lower serum olanzapine concentration and smaller improvements in selected clinical domains.The individual-level analyses did not establish a concentration-response relationship, and the retrospective design precludes causal inference.Haemodynamic safety could not be evaluated because complete standardised blood-pressure data were unavailable.These findings suggest that closer monitoring of clinical response and serum olanzapine concentrations may be considered when amlodipine is co-prescribed, particularly in patients with suboptimal treatment response. | IntroductionSchizophrenia is a chronic mental disorder associated with substantial personal, family, and societal burden (Velligan and Rao 2023).People with schizophrenia also experience marked excess cardiovascular morbidity and premature mortality, driven by an interaction among illness-related factors, smoking, cardiometabolic risk, antipsychotic exposure, and inequalities in physical health care (Correll et al. 2017;Murphy and Daumit 2023;Polcwiartek et al. 2024).Hypertension is therefore a common and clinically important comorbidity in this population (Sudarshan and Cheung 2023).Olanzapine remains widely used because of its efficacy across several symptom domains,
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4249097380
